Agios Pharm
Price & Volume
Stats
See moreOpen | $29.19 |
Previous Close | $30.42 |
Day Range | $28.60-$30.16 |
52W Range | $22.24-$46 |
Market Cap | $1.7B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $66M |
Revenue Growth (YoY) | 137.7% |
Gross Profit (12 Mos) | -$288.4M |
Diluted EPS | -$7.26 |
News
See moreYahoo Finance • 19 hours ago
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
Yahoo Finance • 8 days ago
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
Yahoo Finance • 28 days ago
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
Yahoo Finance • last month
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO)
About
CEO | Mr. Brian M. Goff M.B.A. |
Address | 88 Sidney Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 539 |